Nash, A. L., Ren, Y., Plichta, J. K., Rosenberger, L. H., van den Bruele, A. M. B., DiNome, M. L., … Hwang, E. S. (2023). ASO Visual Abstract: Survival Benefit of Chemotherapy According to 21-Gene Recurrence Score in Young Women with Breast Cancer. Ann Surg Oncol, 30(4), 2140–2141. https://doi.org/10.1245/s10434-022-12885-3

Nash, A. L., Y. Ren, J. K. Plichta, L. H. Rosenberger, A. M. B. van den Bruele, M. L. DiNome, K. Westbrook, and E Shelley Hwang. “ASO Visual Abstract: Survival Benefit of Chemotherapy According to 21-Gene Recurrence Score in Young Women with Breast Cancer.” Ann Surg Oncol 30, no. 4 (April 2023): 2140–41. https://doi.org/10.1245/s10434-022-12885-3.

Nash AL, Ren Y, Plichta JK, Rosenberger LH, van den Bruele AMB, DiNome ML, et al. ASO Visual Abstract: Survival Benefit of Chemotherapy According to 21-Gene Recurrence Score in Young Women with Breast Cancer. Ann Surg Oncol. 2023 Apr;30(4):2140–1.

Nash, A. L., et al. “ASO Visual Abstract: Survival Benefit of Chemotherapy According to 21-Gene Recurrence Score in Young Women with Breast Cancer.” Ann Surg Oncol, vol. 30, no. 4, Apr. 2023, pp. 2140–41. Pubmed, doi:10.1245/s10434-022-12885-3.

Nash AL, Ren Y, Plichta JK, Rosenberger LH, van den Bruele AMB, DiNome ML, Westbrook K, Hwang ES. ASO Visual Abstract: Survival Benefit of Chemotherapy According to 21-Gene Recurrence Score in Young Women with Breast Cancer. Ann Surg Oncol. 2023 Apr;30(4):2140–2141.